These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29125018)

  • 21. An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Fisher R; Magouirk B; Rush AJ
    Schizophr Res; 2006 Jan; 81(2-3):311-6. PubMed ID: 16298106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine in the treatment of neuroleptic-induced blepharospasm: a report of 4 cases.
    Levin H; Reddy R
    J Clin Psychiatry; 2000 Feb; 61(2):140-3. PubMed ID: 10732662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.
    Yusufi B; Mukherjee S; Flanagan R; Paton C; Dunn G; Page E; Barnes TR
    Int Clin Psychopharmacol; 2007 Jul; 22(4):238-43. PubMed ID: 17519648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consistency between clinician and patient ratings of clozapine-induced side effects.
    Takeuchi H; Fervaha G; Remington G
    Schizophr Res; 2016 Jul; 174(1-3):200-201. PubMed ID: 27091657
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.
    Rietschel M; Naber D; Fimmers R; Möller HJ; Propping P; Nöthen MM
    Neuroreport; 1997 May; 8(8):1999-2003. PubMed ID: 9223092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining rates of hepatitis C in a clozapine treated cohort.
    Sockalingam S; Shammi C; Powell V; Barker L; Remington G
    Schizophr Res; 2010 Dec; 124(1-3):86-90. PubMed ID: 20605572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine as a first treatment for schizophrenia.
    Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
    Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early use of clozapine for poorly responding first-episode psychosis.
    Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
    J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.
    Feng S; Melkersson K
    Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study.
    Daniel DG; Goldberg TE; Weinberger DR; Kleinman JE; Pickar D; Lubick LJ; Williams TS
    Am J Psychiatry; 1996 Mar; 153(3):417-9. PubMed ID: 8610833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine.
    Caniato RN; Alvarenga ME; Garcia-Alcaraz MA
    Aust N Z J Psychiatry; 2006 Aug; 40(8):691-7. PubMed ID: 16866765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.
    Mitsonis CI; Dimopoulos NP; Mitropoulos PA; Kararizou EG; Katsa AN; Tsakiris FE; Katsanou MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):373-7. PubMed ID: 17092620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
    Constantine RJ; Andel R; McPherson M; Tandon R
    Psychiatry Res; 2018 May; 263():238-244. PubMed ID: 29195836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
    Nakonezny PA; Byerly MJ; Rush AJ
    Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozaphobia: Is avoidance of clozapine in diabetes warranted?
    Sreeraj VS; Dinakaran D; Nagendrappa S; Rao NP; Kesavan M; Varambally S; Venkatasubramanian G
    Asian J Psychiatr; 2017 Aug; 28():142-145. PubMed ID: 28784368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.
    Zimmet SV; Strous RD; Burgess ES; Kohnstamm S; Green AI
    J Clin Psychopharmacol; 2000 Feb; 20(1):94-8. PubMed ID: 10653215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine treatment in a population of adults with mental retardation.
    Antonacci DJ; de Groot CM
    J Clin Psychiatry; 2000 Jan; 61(1):22-5. PubMed ID: 10695641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.